{"id":"W2787480145","doi":"10.1016/j.jacl.2018.01.013","title":"Alirocumab in high-risk patients: Observations from the open-label expanded use program","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sanofi (Canada)","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Familial hypercholesterolemia; PCSK9; Statin; Internal medicine; Evolocumab; Cholesterol; Lipoprotein; LDL receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001744077,0.0002514427,0.0006408005,0.0002500937,0.0004136091,0.0009293102,0.0002702812,0.000630674,0.00165265],"category_scores_gemma":[0.007291434,0.0001545077,0.0005294477,0.0005386873,0.0003714065,0.001151956,0.0004862301,0.001315925,0.000264925],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004804765,"about_ca_system_score_gemma":0.0006120419,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002310738,"about_ca_topic_score_gemma":0.002630939,"domain_scores_codex":[0.9990307,0.0004469537,0.00006056133,0.0001056753,0.0001940185,0.0001620739],"domain_scores_gemma":[0.9945927,0.00217387,0.00153521,0.0006103339,0.0004682041,0.0006196825],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1034016,0.0104851,0.6979191,0.0001941482,0.0007098273,0.0006227815,0.0008352387,0.0007627265,0.006849437,0.0003938266,0.003108421,0.1747178],"study_design_scores_gemma":[0.003046827,0.01684524,0.9727188,0.00005208544,0.0006144049,0.0004896004,0.0004623227,0.001083943,0.001149112,0.0002799235,0.003224747,0.00003303841],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967129,0.0006408376,0.0001239934,0.000218075,0.00001229159,0.00005389157,0.0003526325,0.000009158356,0.001876311],"genre_scores_gemma":[0.9986264,0.0003275044,0.0001175243,0.0002315547,0.00003370413,0.0000233896,0.0003335243,0.000004498386,0.0003020463],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002310738,"threshold_uncertainty_score":0.00922364,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2118351454886508,"score_gpt":0.4463498752314411,"score_spread":0.2345147297427903,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}